Surveillance of Rotavirus Gastroenteritis (Rotavirus)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02900703|
Recruitment Status : Unknown
Verified September 2016 by Centre Hospitalier Universitaire Dijon.
Recruitment status was: Recruiting
First Posted : September 14, 2016
Last Update Posted : September 14, 2016
- Epidemiological studies have shown the diversity of resistance genotypes and the evolution of their prevalence in the paediatric population. This large study conducted in a context of very low vaccination coverage will generate more precise data on the natural epidemiological evolution of rotavirus, notably the G9 genotype, which has appeared relatively recently.
- This study will allow us to identify and document rare or unusual strains of human or animal origin. The complete genetic characterization of these strains will also make it possible to study their ability to recombine and to assess the risk of emergence. Among these still rare strains, the investigators are particularly monitoring G12 rotavirus, whose ability to recombine raises the risk of emergence.
- For at least one of the centres taking part in the study, the paediatric population studied will be given strong vaccination coverage. It will be extremely interesting to compare the results obtained in the vaccinated population with non-vaccinated children to assess the impact of this vaccination on the distribution of rotavirus genotypes
|Condition or disease||Intervention/treatment|
|Gastroenteritis||Biological: stool samples|
|Study Type :||Observational|
|Estimated Enrollment :||9000 participants|
|Official Title:||Epidemiological Surveillance of Rotavirus Gastroenteritis With a Perspective of Vaccination|
|Study Start Date :||February 2007|
|Estimated Primary Completion Date :||February 2017|
Biological: stool samples
- number of viral strains of rotavirus [ Time Frame: through the completion study an average 10 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02900703
|Contact: Pierre POTHIER||380295487 ext +email@example.com|
|CHU Dijon Bourgogne||Recruiting|
|Dijon, France, 21079|
|Contact: Pierre POTHIER 380295487 ext +33 firstname.lastname@example.org|